跳至主要内容
临床试验/NCT00445107
NCT00445107已完成3 期

An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist

Organon and Co0 个研究点目标入组 198 人开始时间: 2005年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
198
主要终点
Change of the asthma control questionnaire scores taken over 8 weeks

研究概览

简要总结

The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent asthma patients with or without allergic rhinitis.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient is currently a nonsmoker and has been a nonsmoker for at least 1 year
  • •Patient with clinical evidence of mild/moderate asthma with or without allergic rhinitis

排除标准

  • •Patient has been treated in an emergency room for asthma within 4 weeks or has been hospitalized for asthma within 3 months prior to visit 1
  • •Patient with severe asthma, upper respiratory infection, sinusitis, infectious rhinitis, non-allergic rhinitis
  • •Patient has any active, acute, or chronic pulmonary disorder that is documented by history, physical examination

结局指标

主要结局

Change of the asthma control questionnaire scores taken over 8 weeks

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验